Order results by:
Issue | Title | |
Vol 11, No 3 (2015) | ALCOHOL AND HEART RHYTHM DISORDERS | Abstract similar documents |
A. O. Yusupova, A. S. Lishuta | ||
"... complications among other cardiac arrhythmias should use both antiarrhythmic and anti-alcohol drugs ..." | ||
Vol 11, No 2 (2015) | ALCOHOL-INDUCED CARDIAC RHYTHM DISORDERS IN PATIENTS WITH ALCOHOL DEPENDENCE: TYPES OF ARRHYTHMIAS, MECHANISMS OF ORIGIN, PARTICULARITIES OF COURSE AND ANTIARRHYTHMIC THERAPY | Abstract similar documents |
A. S. Aksel'rod, A. L. Syrkin | ||
"... in constant antiarrhythmic therapy within 36 months after the alcohol cessation, and patients with paroxysmal ..." | ||
Vol 10, No 1 (2014) | ALCOHOL AND ARTERIAL HYPERTENSION | Abstract similar documents |
O. D. Ostroumova, E. V. Saperova | ||
"... The article considers the questions of the relationship between the amount of the consumed alcohol ..." | ||
Vol 11, No 6 (2015) | Alcohol consumption in patients with cardiovascular diseases (results of the survey of cardiac patients in outpatient practice) | Abstract similar documents |
O. D. Ostroumova, I. E. Nikolaeva, S. Ya. Eregin, I. V. Pokrovskaya, K. A. Ishchenko | ||
"... Aim. To study the frequency and characteristics of alcohol use in outpatients with cardiovascular ..." | ||
Vol 10, No 6 (2014) | ALCOHOLIC CARDIOMYOPATHY: BASIC ASPECTS OF EPIDEMIOLOGY, PATHOGENESIS AND PHARMACOTHERAPY | Abstract similar documents |
A. O. Yusupova | ||
"... . Psychotropic therapy aimed at reduction in motivation to alcohol consumption in patients with ACMP is discussed ..." | ||
Vol 4, No 4 (2008) | DANGER OF ALCOHOL FOR PATIENTS WITH ARTERIAL HYPERTENSION DURING ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
M. P. Savenkov, M. K. Danilova, S. N. Ivanov, A. M. Savenkova, S. V. Ivanova | ||
"... Aim. To develop a test on tolerability of small alcohol doses (SAD), to study hemodynamic ..." | ||
Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
"... алкогольной кардиомиопатией (АКМП; n=43). Пациенты групп ИДКМП и АКМП рандомизированы в группы лечения ..." | ||
Vol 18, No 1 (2022) | Prognostic Significance of the Integral Index of the Alcohol Situation in Assessing Regional Differences in Mortality from Cardiovascular Diseases in the Russian Federation | Abstract similar documents |
B. E. Gornyi, A. M. Kalinina, O. M. Drapkina | ||
"... Aim. To evaluate the stability of the integral index of the alcohol situation in the regions ..." | ||
Vol 12, No 2 (2016) | ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION | Abstract similar documents |
Ju. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolaev | ||
"... Modern approaches to antiarrhythmic anti-relapse therapy of atrial fibrillation are considered ..." | ||
Vol 18, No 3 (2022) | Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice | Abstract similar documents |
V. L. Doshchitsin, A. I. Tarzimanova | ||
"... the second half of the 20th century, when new antiarrhythmic drugs began to be used in clinical practice ..." | ||
Vol 7, No 3 (2011) | PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
V. A. Sulimov, A. S. Lishuta | ||
Vol 6, No 6 (2010) | THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS | Abstract similar documents |
Yu. A. Bunin | ||
"... различных антиаритмических препаратов в профилактике смерти у больных с ЖА. Подчёркивается, что у больных с ..." | ||
Vol 15, No 1 (2019) | Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality? | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... type. Emerging genetic studies provided explanation for the variable efficacy of antiarrhythmic drugs ..." | ||
Vol 12, No 4 (2016) | Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs | Abstract similar documents |
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva | ||
"... Use of class I antiarrhythmic drugs in the elderly is limited by their adverse drug reactions (ADRs ..." | ||
Vol 12, No 5 (2016) | Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs | Abstract similar documents |
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva | ||
"... The effectiveness of antiarrhythmic drugs in the elderly is similar to that in younger patients ..." | ||
Vol 5, No 1 (2009) | CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY | Abstract similar documents |
Yu. A. Bunin | ||
"... stratification) of different antiarrhythmic drugs and anticoagulants are described. Perspectives in improvement ..." | ||
Vol 11, No 4 (2015) | CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova, I. Z. Loriya | ||
"... atrial fibrillation (AF) treated with various antiarrhythmic drugs. Material and methods. Patients ..." | ||
Vol 19, No 3 (2023) | Ventricular tachycardia and myocardial infarction during antiarrhythmic therapy: a case report | Abstract similar documents |
A. A. Gurbanova, K. G. Pereverzeva, S. S. Yakushin, I. V. Budanova | ||
"... failure. In 2020, the patient was diagnosed with ventricular extrasystole and started antiarrhythmic ..." | ||
Vol 3, No 4 (2007) | PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY | Abstract similar documents |
B. A. Tatarskii | ||
"... used to terminate of atrial fibrillation are given. The choice of antiarrhythmic drug is considerate ..." | ||
Vol 3, No 5 (2007) | EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION | Abstract similar documents |
L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov | ||
"... of preventive antiarrhythmic therapy in patients with paroxysmal atrial fibrillation (AF). Material and methods ..." | ||
Vol 14, No 5 (2018) | Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation | Abstract similar documents |
M. H. Fedorova, V. L. Doshchitsin, A. V. Chapurnykh | ||
"... Aim. Comparison of different treatment tactics – medicated antiarrhythmic therapy (AAT ..." | ||
Vol 16, No 5 (2020) | Effect of Amiodarone, Sotalol and Bisoprolol on Heart Rate Variability in Patients with Atrial Fibrillation | Abstract similar documents |
E. P. Popova, S. S. Puzin, O. T. Bogova, S. N. Puzin, D. A. Sychev, V. P. Fisenko | ||
"... Aim. To study the effect of class III antiarrhythmic drugs (amiodarone and sotalol), and the β ..." | ||
Vol 18, No 2 (2022) | Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases | Abstract similar documents |
A. N. Zakirova, N. E. Zakirova | ||
"... antiarrhythmic effects, improving endothelial function, showing an anti- inflammatory effect, affecting ..." | ||
Vol 7, No 6 (2011) | NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina | ||
"... electrophysiological properties attributable to all four classes of antiarrhythmic drugs. According to meta-analysis ..." | ||
Vol 19, No 2 (2023) | Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease | Abstract similar documents |
D. A. Tsaregorodtsev, M. A. Khalikova, S. S. Vasyukov, M. M. Beraya, A. V. Sedov | ||
"... within 6 and 12 months from the onset of antiarrhythmic drug therapyand in RFA and CRYO groups – within 6 ..." | ||
Vol 13, No 6 (2017) | ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY | Abstract similar documents |
Yu. А. Bunin, S. V. Miklishanskaya | ||
"... antiarrhythmics and not antiarrhythmic drugs, anticoagulants and non-drug treatments in these patients. Based ..." | ||
Vol 21, No 2 (2025) | Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion | Abstract similar documents |
Kh. M. Dzaurova, N. Yu. Mironov, Yu. A. Yuricheva, M. M. Belyaeva, S. F. Sokolov, N. A. Mironova, S. P. Golitsyn, O. Yu. Korennova, I. M. Zueva, E. A. Turusheva, D. S. Terekhov | ||
Vol 2, No 1 (2006) | PROPAFENONE FOR SINUS RHYTHM RECOVERY AND SUPPORT IN PATIENTS WITH PERSISTENT FORM OF AURICULAR FIBLILLATION. “PROMETHEUS” – OPENED MULTICENTER STUDY IN RUSSIAN FEDERATION | Abstract similar documents |
I. G. Fomina, A. I. Tarzimanova, A. V. Vetluzsky, , , , , , , , , , , , , , , , , | ||
"... mg. Efficiency of sustaining antiarrhythmic therapy was assessed in 1, 3 and 9 months after ..." | ||
Vol 17, No 2 (2021) | Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness | Abstract similar documents |
N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin | ||
"... Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon ..." | ||
Vol 17, No 5 (2021) | Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety | Abstract similar documents |
N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin | ||
"... Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon ..." | ||
Vol 13, No 1 (2017) | COMPARISON OF EFFECTIVENESS OF ANTIARRHYTHMIC THERAPIES IN POSTOPERATIVE PERIOD OF PULMONARY VEIN OSTIA CATHETER ISOLATION FOR PREVENTION OF EARLY RECURRENCES OF ATRIAL TACHYARRHYTHMIAS IN THE PROOF STUDY | Abstract similar documents |
A. V. Tarasov, K. V. Davtyan, S. Yu. Martsevich | ||
"... . Aim. To study the effectiveness of antiarrhythmic drugs: propafenone, sotalol and verapamil ..." | ||
Vol 8, No 2 (2012) | 1C-INDUCED ATRIAL FLUTTER IN A PATIENT WITH WPW SYNDROME: CASE REPORT AND REVIEW | Abstract similar documents |
R. R. Mamatkazina, I. P. Kolos, S. E. Serdyuk, E. P. Mazygula, A. V. Sveshnikov | ||
"... The clinical case of a rare proarrhythmic effect of antiarrhythmic drugs with a poor prognosis ..." | ||
Vol 7, No 1 (2011) | ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION | Abstract similar documents |
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov | ||
"... Aim. To assess propafenone antiarrhythmic efficacy and optimal timing of the drug administration ..." | ||
Vol 9, No 1 (2013) | THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS | Abstract similar documents |
A. O. Malygin, V. L. Doshchitsin | ||
"... Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic ..." | ||
Vol 4, No 3 (2008) | DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY | Abstract similar documents |
E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin | ||
"... antiarrhythmic therapy) and second group (basic antiarrhythmic therapy and atorvastatin (Liptonorm, Pharmstandart ..." | ||
Vol 5, No 6 (2009) | COMPARATIVE EFFICACY OF AMIODARONE AND BISOPROLOL IN TREATMENT OF VENTRICULAR PREMATURE BEATS IN PATIENTS WITH METABOLIC SYNDROME | Abstract similar documents |
V. M. Provotorov, M. L. Gluhovsky | ||
"... patients did not receive any antiarrhythmic therapy (control group). Treatment efficacy was evaluated ..." | ||
Vol 19, No 1 (2023) | Relief of persistent atypical atrial flutter: experience with the use of niferidil | Abstract similar documents |
E. A. Zakharyan, D. V. Shatov, A. O. Povoroznyj, T. B. Bujar | ||
"... is not absolute, and therefore the development and introduction of new antiarrhythmic drugs is particularly ..." | ||
Vol 15, No 2 (2019) | Ventricular Tachycardia Induced by Exercise Test as a Predictor of Coronary Artery Disease Development | Abstract similar documents |
A. A. Tatarinova, E. A. Ryngach, T. V. Treshkur, D. V. Ryzhkova, O. N. Zhdanova, D. V. Svalov | ||
"... antiarrhythmic effect of the therapy with a metabolic drug (treatment with a beta-blocker was impossible because ..." | ||
Vol 9, No 3 (2013) | CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION | Abstract similar documents |
N. V. Furman, S. S. Shmatova | ||
"... that a wide range of both antiarrhythmic and non-cardiac medications might lead to QT interval prolongation ..." | ||
Vol 17, No 3 (2021) | Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome | Abstract similar documents |
A. Yu. Proshlyakov, P. Sh. Chomakhidze, N. A. Novikova | ||
"... of cardiac arrest, and do not have a permanent prescribed antiarrhythmic therapy, the mortality rate reaches ..." | ||
Vol 14, No 4 (2018) | Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment | Abstract similar documents |
Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova | ||
"... . The irrationality, and sometimes the risk of carrying out prophylactic antiarrhythmic therapy for AF and VA ..." | ||
Vol 17, No 2 (2021) | Rotor Drivers in Induction and Maintenance of Atrial Fibrillation | Abstract similar documents |
A. A. Kulikov, O. V. Sapelnikov, T. M. Uskach, D. I. Cherkashin, I. R. Grishin, R. S. Akchurin | ||
"... and maintaining sinus rhythm have a very limited effect, both in the case of antiarrhythmic and catheter treatment ..." | ||
Vol 5, No 4 (2009) | ANTIARRHYTMIC EFFICACY OF SOTALOL IN PATIENTS WITH TACHY-BRADY SYNDROME HAVING ATRIAL PACEMAKER WITH DIFFERENT ATRIAL ELECTRODE POSITION | Abstract similar documents |
T. N. Novikova | ||
Vol 2, No 1 (2006) | SUPRAVENTRICULAR RHYTHM DISTURBANCES TREATMENT WITH ANTIARHYTHMIC DRUG III CLASS NIBENTAN IN PATIENTS WITH ISCHEMIC HEART DISEASE (EXPERIMENTAL, CLINICAL AND MORPHOLOGICAL EVIDENCES) | Abstract similar documents |
I. A. Latfullin, R. F. Gaifullina | ||
"... Цель. Оценить антиаритмическую эффективность нибентана (Верофарм, Россия) антиаритмического ..." | ||
Vol 9, No 6 (2013) | DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? | Abstract PDF (Eng) similar documents |
V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi | ||
"... of antiarrhythmic drugs may be regarded as one of the myths of modern cardiology. Multiple references to negative ..." | ||
Vol 17, No 5 (2021) | Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias | Abstract similar documents |
O. V. Blagova, A. V. Nedostup, E. A. Kogan | ||
"... with myocarditis. Initially, in 62.5% of patients a resistance of AF to all antiarrhythmic drugs was noted. After ..." | ||
Vol 19, No 1 (2023) | A Case of Successful Medical Treatment of Ventricular Tachycardia in a Patient With Ischemic Heart Disease and Heart Failure | Abstract similar documents |
E. A. Ryngach, A. A. Tatarinova, E. S. Zhabina, O. N. Zhdanova, T. V. Treshkur | ||
"... with a good antiarrhythmic result that persists for several years of observation. Conducting mental tests ..." | ||
Vol 17, No 3 (2021) | An Integrated Approach to the Management of a Multimorbid Patient with Atrial Fibrillation from the Standpoint of Modern Guidelines: Rivaroxaban is in Focus | Abstract similar documents |
V. N. Larina, O. Sh. Oynotkinova, A. P. Majorova, G. A. Egiazarian, T. Yu. Demidova | ||
"... and / or its frequency, choosing between ablation, cardioversion and antiarrhythmic drugs, as well ..." | ||
Vol 13, No 4 (2017) | ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION: GENDER DIFFERENCES OF VENTRICULOATRIAL REMODELING WITH PRESERVED EJECTION FRACTION | Abstract similar documents |
Zh. D. Kobalava, E. V. Kokhan, G. K. Kiyakbaev, A. A. Shavarov | ||
"... cardiovascular mortality, heart failure, thromboembolic events, bleedings, severe side effects of antiarrhythmic ..." | ||
Vol 16, No 3 (2020) | The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... of ω-3 PUFA can be considered their anti-atherogenic effect. Antiarrhythmic properties of го-3 PUFA ..." | ||
Vol 17, No 6 (2021) | Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia | Abstract similar documents |
D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash | ||
"... and income, marital status) and the presence of behavioral risk factors (tobacco and alcohol use). Results ..." | ||
Vol 14, No 5 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness | Abstract similar documents |
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
"... Aim. We aimed to compare effectiveness of new class III antiarrhythmic drug Refralon with direct ..." | ||
Vol 6, No 5 (2010) | PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE | Abstract similar documents |
M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva | ||
"... , hypertension, diabetes mellitus), as well as certain risk factors (smoking, alcohol abuse, physical inactivity ..." | ||
Vol 14, No 6 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety | Abstract PDF (Eng) similar documents |
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
"... Aim. To compare safety of new class III antiarrhythmic drug Refralon with direct current ..." | ||
Vol 19, No 1 (2023) | The Study of Adherence to Drug Therapy at the Stage of Outpatient Follow-up in Patients with Acute Myocardial Infarction (Data from the PROFIL-IM Registry) | Abstract similar documents |
E. P. Kalaydzhyan, N. P. Kutishenko, Yu. V. Lukina, D. P. Sichinava, S. Yu. Martsevich, O. M. Drapkina | ||
"... of adherence with the male sex, the presence of hypertension, a feedback relationship with alcohol consumption ..." | ||
Vol 6, No 2 (2010) | REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT | Abstract similar documents |
A. N. Britov, M. M. Bystrova | ||
"... resistance. Obesity, salt and alcohol overconsumption, taking some drugs worsen BP control. Secondary HT ..." | ||
Vol 10, No 2 (2014) | CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part II (Treatment) | Abstract similar documents |
O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. A. Sulimov, Yu. V. Osipova, V. P. Sedov, A. G. Kupriyanova, V. A. Zaydenov, A. E. Donnikov, V. V. Kadochnikova | ||
"... of the emantiarrhythmic/em effect of treatment in patients with IA, a significant increase in ejection fraction, a reducing ..." | ||
Vol 15, No 5 (2019) | Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis | Abstract similar documents |
L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok | ||
"... , and emantiarrhythmics/em (p0.001). Pentoxifylline was prescribed more often in the first group (p0.001). With a three ..." | ||
Vol 13, No 6 (2017) | HEART RATE AND ITS ASSOCIATION WITH THE MAIN RISK FACTORS IN THE POPULATION OF MEN AND WOMEN OF WORKING AGE | Abstract similar documents |
S. А. Shalnov, A. D. Deev, O. A. Belova, Yu. I. Grinshtein, D. V. Duplyakov, A. Yu. Efanov, E. V. Indukaeva, N. V. Kulakova, R. A. Libis, S. V. Nedogoda, O. P. Rotar, G. V. Tolparov, I. A. Trubacheva, T. M. Chernykh, A. A. Shabunova, S. A. Boytsov | ||
"... and quitters (OR 1.90, 95% CI 1.63-2.27), who did not drink emalcohol/em during the last year (OR 1.18, 95% CI 1 ..." | ||
Vol 17, No 2 (2021) | Main Factors Related with the White Coat Effect Level in Patients with Arterial Hypertension and Bronchial Asthma | Abstract similar documents |
G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Y. N. Koshelyaevskaya | ||
"... . In AH patients without BA with ischemic heart disease, arterial revascularization, regular emalcohol/em ..." | ||
Vol 10, No 2 (2014) | HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY) | Abstract similar documents |
S. A. Shalnova, A. D. Deev, G. V. Artamonov, D. V. Duplyakov, A. Yu. Efanov, Yu. V. Zhernakova, A. O. Konradi, R. A. Libis, G. A. Muromtseva, S. V. Nedogoda, E. V. Oschepkova, S. V. Romanchuk, O. P. Rotar, V. N. Titov, Z. A. Toguzova, I. A. Trubacheva, G. I. Furmenko, E. V. Shlyakhto, S. A. Boytsov | ||
"... , obesity and abdominal obesity, emalcohol/em consumption and diuretics taking. After adjustment for all factors ..." | ||
Vol 17, No 6 (2021) | Hyperuricemia: Features of the Diet | Abstract similar documents |
O. B. Shvabskaia, O. V. Izmailova, N. S. Karamnova, O. M. Drapkina | ||
"... with the consumption of foods rich in purines (offal, red meat, fish, seafood, legumes), emalcohol/em consumption, drinks ..." | ||
Vol 14, No 5 (2018) | Basic Anthropometric Indices and Diabetes Mellitus Type 2 in Russian Population | Abstract similar documents |
O. M. Drapkina, R. N. Shepel, S. A. Shalnova, A. D. Deev, Yu. A. Balanova, S. E. Evstifeeva, Yu. V. Zhernakova, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, O. P. Rotar, E. V. Shlyakhto, S. A. Boytsov | ||
"... smoked”, “smoked”, “smokes now”); emalcohol/em consumption, which was ranked for “never in the last year ..." | ||
Vol 13, No 4 (2017) | HEALTHCARE RESOURCES UTILIZATION AND TEMPORARY DISABILITY IN POPULATION AGED 50-64 ACCORDING TO THE EPIDEMIOLOGICAL ESSE-RF STUDY | Abstract PDF (Eng) similar documents |
A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, A. D. Deev, A. V. Kapustina, G. A. Muromtseva, S. E. Evstifeeva, S. A. Shalnova | ||
"... and moderate emalcohol/em consumption were hospitalized and called an ambulance significantly less often than those ..." | ||
Vol 17, No 3 (2021) | Causes, Predisposing Factors and Prevention Directions of Drug-induced Bradycardia (Based on the Results of the Hospital Register of Oardiac Medications Overdoses STORM) | Abstract similar documents |
N. N. Nikulina, S. V. Seleznev, M. B. Chernysheva, S. S. Yаkushin | ||
"... - an average of 64.3%, emantiarrhythmic/em drugs with BCA- 41.0%, cardiac glycosides 25.1% (frequency each ..." | ||
Vol 15, No 6 (2019) | Association of Self-Perceived Health with Social and Psychological Environment, the Mode of Life and Cardiovascular Risk Markers in Middle-Aged Men – Residents of Moscow | Abstract PDF (Eng) similar documents |
M. B. Kotova, V. B. Rozanov, E. I. Ivanova | ||
"... blood pressure (BP), abdominal obesity, excessive emalcohol/em consumption, psychosocial stress, vital ..." | ||
Vol 4, No 4 (2008) | PRIORITIES IN CONCEPT OF CARDIOVASCULAR RISK FACTORS IN IRRADIATED PATIENTS AT DISTANT PERIOD AFTER CHERNOBYL NUCLEAR DISASTER BASED ON PROSPECTIVE COHORT DATA | Abstract similar documents |
R. G. Oganov, V. S. Sherashov, N. V. Sherashova, M. V. Sherashova, S. K. Kukushkin, O. G. Rudakova, E. A. Zhavoronkova | ||
"... of standard questionnaires, social and demographic description, education, family status, smoking and emalcohol/em ..." | ||
Vol 12, No 1 (2016) | The main factors affecting the long-term outcomes in patients after acute cerebrovascular disorder: results of the LIS-2 study | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, A. V. Suvorov, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev | ||
"... =1.1). The probability of death increased in the presence of diabetes mellitus (RR=1.4), emalcohol/em ..." | ||
Vol 15, No 3 (2019) | Features of Atrial Fibrillation in Patients with Arterial Hypertension and Extracardial Disorders | Abstract similar documents |
L. D. Khidirova, D. A. Yakhontov, S. A. Zenin, M. N. Mamedov | ||
"... assessment of risk factors (smoking and emalcohol/em) did not show significant differences in prevalence ..." | ||
Vol 15, No 2 (2019) | Screening of People with High Blood Pressure in Moscow Region | Abstract similar documents |
O. M. Drapkina, R. N. Shepel, E. S. Ivanova, E. S. Bulgakova, A. N. Kaburova, L. M. Zhamalov, Yu. D. Shalyagin, A. V. Kutcher, S. A. Vernadskiy | ||
"... a questionnaire: age, gender, height and weight, previous BP measurement date, bad habit (tobacco smoking, emalcohol/em ..." | ||
Vol 15, No 4 (2019) | The Association of Smoking Status and Intensity of Smoking with Blood Lipid Spectrum in a Sample of Middle-Aged Men | Abstract similar documents |
A. A. Alexandrov, V. B. Rozanov, M. B. Kotova, V. A. Dadaeva, E. I. Ivanova | ||
"... on a standard questionnaire (passport data, the presence of bad habits [smoking, emalcohol/em consumption]), a three ..." | ||
Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
M. M. Batiushin | ||
"... and progression of CKD. Currently, Smoking, emalcohol/em, and physical inactivity have been shown to have a harmful ..." | ||
Vol 16, No 6 (2020) | Association of Smoking with Indicators of the Structure and Function of Blood Vessels in Middle-aged Men | Abstract similar documents |
O. Yu. Isaykina, V. B. Rozanov, А. А. Aleksandrov, M. B. Kotova | ||
"... was attributable to current smoking combined with variability in emalcohol/em consumption, blood glucose, and heart rate ..." | ||
Vol 15, No 3 (2019) | The Prevalence of Smoking in 41-43-Year-Old Males and its Relation to Some Risk Factors | Abstract PDF (Eng) similar documents |
A. A. Alexandrov, M. V. Kotova, E. I. Ivanova, V. B. Rozanov | ||
"... by a standard questionnaire (the passport data, the level of physical activity, bad habits – smoking, emalcohol/em ..." | ||
Vol 17, No 5 (2021) | Social Network-Based Digital Stroke Prevention: Opportunities, Results and Prospects | Abstract PDF (Eng) similar documents |
A. E. Demkina, M. V. Bezzubtseva, M. N. Ryabinina, Ya. A. Kotlyar, O. L. Keln, А. V. Sarapulova, R. R. Zhetishev, V. S. Kuvaev, M. Y. Maksimova, N. V. Pogosova, I. V. Zhetisheva | ||
"... the stroke risk factors for diabetes mellitus, other cardiovascular diseases (CVD), obesity, and emalcohol/em use ..." | ||
Vol 20, No 2 (2024) | Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring? | Abstract similar documents |
D. Yu. Sedykh, T. S. Alkhimova, V. V. Kashtalap, O. L. Barbarash | ||
"... .8 times more likely to indicate a decrease in the frequency of monthly emalcohol/em consumption and a decrease ..." | ||
Vol 6, No 3 (2010) | SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION | Abstract similar documents |
D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko | ||
"... Амиодарон считается одним из ведущих emантиаритмических/em препаратов в лечении фибрилляции предсердий ..." | ||
Vol 6, No 6 (2010) | THE USE OF AMIODARONE IN CLINICAL PRACTICE: THE PROBLEM OF SIDE EFFECTS | Abstract similar documents |
O. V. Gaisenok | ||
"... и подходам к лечению. Кроме того, отражены перспективы новых emантиаритмических/em препаратов III класса ..." | ||
Vol 15, No 5 (2019) | Outpatient Register of Patients with Acute Myocardial Infarction: Assessment of the Hypertension Impact on Long-term Prognosis | Abstract similar documents |
D. P. Sichinava, E. P. Kalaydzhyan, N. P. Kutishenko, S. Yu. Martsevich | ||
"... .1%, respectively) and drank emalcohol/em (30.5% and 52.4%, respectively), p0.05 for both; more likely to visit ..." | ||
Vol 3, No 3 (2007) | COMPARATIVE EFFECTS OF MONOTHERAPY WITH MAGNESIUM AND COMBINED THERAPY WITH MAGNESIUM AND Β-BLOCKER ON PRIMARY MITRAL VALVE PROLAPSE WITH HEART RHYTHM DISORDERS | Abstract similar documents |
E. G. Nurtdinova, A. N. Zakirova, T. B. Khairetdinova | ||
"... of the autonomic dysfunction syndrome, ECG positive dynamics, emantiarrhythmic/em effect, decrease in the degree ..." | ||
Vol 18, No 1 (2022) | Aging Challenges. Perceived Age – a New Predictor of Longevity? | Abstract similar documents |
S. A. Shalnova, N. A. Imaeva, A. E. Imaeva, A. V. Kapustina | ||
"... , среди которых курение, систематическое потребление emалкогольных/em напитков, избыточная или недостаточная ..." | ||
1 - 83 of 83 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)